Early Efficacy of Clone RMP-14 O of PD-1 antibody inveiled/
A new study demonstrates that ichorbio's RMP1-14 (ICH1132) Clone shows significant early-stage efficacy and a consistent performance profile in tumor growth inhibition studies against Competitor B.
Key Benefits:
|
||||||||||||||||||||||||||||||||